Skip to main content
OpenTrials
Completed

NCT Number: NCT00546858

Relationship of Interstitial Cystitis to Vulvodynia

This study is important in urologic nursing since many patients have interstitial cystitis (IC), a condition of frequency, urgency and pain affecting more than 1 million women in the United States. The vulva may actually be the site of some of the reported pain in women with IC, not the urethra or bladder. IC and vulvodynia can impact one's sexual functioning and diminish one's quality of life.

The purpose of this two-part study is to identify and clinically confirm the presence of vulvodynia in women diagnosed with Interstitial Cystitis (IC).

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Females who are 18 years of age and older.
  • Diagnosis of interstitial cystitis

Treatment and study plan

physical examination

Other

Patients will be invited to be evaluated in the Urology Research office at a future date.

Primary outcomes

  1. The purpose of this two-part study is to identify and clinically confirm the presence of vulvodynia in women diagnosed with Interstitial Cystitis (IC).

    Time frame: Prospective

Sponsors and collaborators

Lead sponsor

Corewell Health East

Other

Registry information

Official study title

Part A: STUDY OF THE RELATIONSHIP OF INTERSTITIAL CYSTITIS TO VULVODYNIA

Important dates

Study start
2007
Primary completion
2009
Study completion
2009
First posted
Oct 19, 2007
Registry last updated
May 5, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.